Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating a preventive intervention called Condensed Internet-delivered Prolonged Exposure CIPE for people experiencing symptoms of post-traumatic stress disorder PTSD about one month after a traumatic event. The goal is to test the effectiveness and cost-effectiveness of CIPE when added to usual treatment provided by psychosocial crisis teams in Norwegian municipalities. This study addresses the lack of evidence-based preventive interventions available for victims after crises and disasters in Norway. Participants are randomly assigned to receive either treatment-as-usual TAU alone or TAU plus the CIPE intervention. CIPE is a therapist-supported, internet-based program consisting of four modules delivered over six weeks. Participants are encouraged to engage daily with their therapist through a secure platform and may have phone sessions. The total therapist contact is generally under 60 minutes, while participants work on intervention tasks about six hours weekly. TAU involves proactive support from interdisciplinary crisis teams following national guidelines. Throughout the one-year study period after trauma, participants undergo assessments including the PTSD Checklist for DSM-5 at 10 to 13 weeks, 6 months, and 12 months post-trauma. Other measures include depression, insomnia, grief symptoms, treatment satisfaction, and quality of life. Researchers will monitor use of specialized mental health services and cost-effectiveness. The study aims to understand how CIPE plus usual care compares to usual care alone in reducing PTSD symptoms and improving overall outcomes.
Actively Recruiting
Researchers are evaluating the effects of Medisinstart, a pharmacy counseling service, among adults starting new medication for type 2 diabetes. This randomized controlled trial aims to understand how Medisinstart influences medication use and patient adherence, which is important for improving health outcomes and benefits for patients and society. The study compares Medisinstart with usual prescription dispensing without additional counseling. Participants in the intervention group receive two follow-up consultations with a pharmacist as part of Medisinstart, while the control group receives standard prescription dispensing. The study collects data through blood tests measuring HbA1c, an established indicator of blood sugar control, and questionnaires assessing medication adherence, beliefs about medicines, diabetes self-management, and treatment satisfaction at baseline, 6 months, and 12 months after starting the new medication. During the study, participants provide blood samples for HbA1c analysis and complete questionnaires to report on their medication use and diabetes management. Researchers monitor medication-related problems and patient beliefs about medicines during the follow-up consultations. The main outcomes measured include HbA1c levels at baseline, 6 months, and 12 months, with additional assessments of adherence and treatment satisfaction over the same periods. The total study duration for each participant spans one year after starting the new diabetes medication.